These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 30094520)
1. Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature. McEvoy K; Payne JL; Osborne LM Curr Psychiatry Rep; 2018 Aug; 20(9):78. PubMed ID: 30094520 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis. Deligiannidis KM; Kroll-Desrosiers AR; Tan Y; Dubuke ML; Shaffer SA Psychoneuroendocrinology; 2020 Nov; 121():104827. PubMed ID: 32828068 [TBL] [Abstract][Full Text] [Related]
3. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Uzunova V; Sampson L; Uzunov DP Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906 [TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway. Hellgren C; Comasco E; Skalkidou A; Sundström-Poromaa I Horm Behav; 2017 Aug; 94():106-113. PubMed ID: 28666923 [TBL] [Abstract][Full Text] [Related]
6. Metabolites of progesterone in pregnancy: Associations with perinatal anxiety. Etyemez S; Miller KN; Voegtline KM; Özdemir İ; Standeven LR; Santovito LS; Pinna G; Payne JL; Osborne LM Psychoneuroendocrinology; 2023 Oct; 156():106327. PubMed ID: 37423029 [TBL] [Abstract][Full Text] [Related]
7. The role of allopregnanolone in depression and anxiety. Schüle C; Nothdurfter C; Rupprecht R Prog Neurobiol; 2014 Feb; 113():79-87. PubMed ID: 24215796 [TBL] [Abstract][Full Text] [Related]
8. Neuroactive steroids - new possibilities in the treatment of postpartum depression. Žigová L; Massarová P; Vranecová K; Hrubá O; Adamičková A; Gažová A Ceska Slov Farm; 2022; 71(4):142-150. PubMed ID: 36208918 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development. Frieder A; Fersh M; Hainline R; Deligiannidis KM CNS Drugs; 2019 Mar; 33(3):265-282. PubMed ID: 30790145 [TBL] [Abstract][Full Text] [Related]
10. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. Deligiannidis KM; Sikoglu EM; Shaffer SA; Frederick B; Svenson AE; Kopoyan A; Kosma CA; Rothschild AJ; Moore CM J Psychiatr Res; 2013 Jun; 47(6):816-28. PubMed ID: 23499388 [TBL] [Abstract][Full Text] [Related]
11. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression. Deligiannidis KM; Kroll-Desrosiers AR; Mo S; Nguyen HP; Svenson A; Jaitly N; Hall JE; Barton BA; Rothschild AJ; Shaffer SA Psychoneuroendocrinology; 2016 Aug; 70():98-107. PubMed ID: 27209438 [TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study. Standeven LR; Osborne LM; Betz JF; Yenokyan G; Voegtline K; Hantsoo L; Payne JL Arch Womens Ment Health; 2022 Apr; 25(2):521-526. PubMed ID: 34714413 [TBL] [Abstract][Full Text] [Related]
13. Neuroactive steroids in pregnancy: key regulatory and protective roles in the foetal brain. Hirst JJ; Kelleher MA; Walker DW; Palliser HK J Steroid Biochem Mol Biol; 2014 Jan; 139():144-53. PubMed ID: 23669456 [TBL] [Abstract][Full Text] [Related]
14. Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum. Dichtel LE; Lawson EA; Schorr M; Meenaghan E; Paskal ML; Eddy KT; Pinna G; Nelson M; Rasmusson AM; Klibanski A; Miller KK Neuropsychopharmacology; 2018 May; 43(6):1436-1444. PubMed ID: 29090684 [TBL] [Abstract][Full Text] [Related]
15. Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Schiller CE; Schmidt PJ; Rubinow DR Psychopharmacology (Berl); 2014 Sep; 231(17):3557-67. PubMed ID: 24846476 [TBL] [Abstract][Full Text] [Related]
16. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone. Standeven LR; Olson E; Leistikow N; Payne JL; Osborne LM; Hantsoo L Curr Psychiatry Rep; 2021 Apr; 23(6):36. PubMed ID: 33881645 [TBL] [Abstract][Full Text] [Related]
17. Neurosteroids in the fetus and neonate: potential protective role in compromised pregnancies. Hirst JJ; Palliser HK; Yates DM; Yawno T; Walker DW Neurochem Int; 2008; 52(4-5):602-10. PubMed ID: 17850922 [TBL] [Abstract][Full Text] [Related]
18. Development of neuroactive steroids for the treatment of postpartum depression. Gunduz-Bruce H; Takahashi K; Huang MY J Neuroendocrinol; 2022 Feb; 34(2):e13019. PubMed ID: 34462985 [TBL] [Abstract][Full Text] [Related]
19. Neuroactive steroids and depression in early pregnancy. Wenzel ES; Pinna G; Eisenlohr-Moul T; Bernabe BP; Tallon RR; Nagelli U; Davis J; Maki PM Psychoneuroendocrinology; 2021 Sep; 134():105424. PubMed ID: 34607173 [TBL] [Abstract][Full Text] [Related]
20. Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms. Maitra R; Reynolds JN Can J Physiol Pharmacol; 1998 Sep; 76(9):909-20. PubMed ID: 10066142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]